cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: Role in modulating MyoD half-life and myogenic activity

Molecular and Cellular Biology

Volumn 19, Issue 4, 1999, Pages 3167-3176

  Kitzmann, Magali ^a   Vandromme, Marie ^a   Schaeffer, Valerie ^a   Carnac, Gilles ^a   Labbé, Jean Claude ^a   Lamb, Ned ^a   Fernandez, Anne ^a  

^a INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; MYOD PROTEIN; PROLINE; SERINE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALIA; TRIXIS;

EID: 0032935671     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.4.3167     Document Type: Article

References (58)

1. Akhurst, R. J., N. B. Flavin, J. Worden, and M. G. Lee. 1989. Intracellular localisation and expression of mammalian CDC2 protein during myogenic differentiation. Differentiation 40:36-41.
2. Andrés, V., and K. Walsh. 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132:657-666.
3. Benezra, R., R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
4. Braun, J., G. Buschhausen-Denken, E. Bober, E. Tannich, and H. H. Arnold. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 8:701-709.
5. Brennan, T. J., D. G. Edmonson, and E. N. Olson. 1991. Transforming growth factor beta represses the actions of myogenin through a mechanism independent of DNA binding. Proc. Natl. Acad. Sci. USA 88:3822-3826.
6. Choi, J., M. L. Costa, C. S. Mermelstein, C. Chagas, S. Holtzer, and H. Holtzer. 1990. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc. Natl. Acad. Sci. USA 87:7988-7992.
7. Crescenzi, M., T. P. Fleming, A. B. Lassar, H. Weintraub, and S. A. Aaronson. 1990. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. USA 87:8442-8446.
8. Davis, R. L., H. Weintraub, and A. B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
9. Davis, R. L., P. Cheng, A. B. Lassar, and H. Weintraub. 1990. The MyoD DNA binding domain contains a recognition code for muscle specific gene activation. Cell 60:733-746.
10. Deed, R W., E. Hara, G. T. Atherton, G. Peters, and J. D. Norton. 1997. Regulation of Id3 cell cycle function by cdk2-dependent phosphorylation. Mol. Cell. Biol. 17:6815-6821.
11. Eckner, R., T. P. Yao, E. Oldread, and D. Livingston. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478-2490.
12. Edmonson, D. G., and E. N. Olson. 1989. A gene with homology to the myc simulatory region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3:628-640.
13. Gerber, A. N., T. R. Klesert, D. A. Bergstrom, and S. J. Tapscott. 1997. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 11:436-450.
14. Gu, W., J. W. Schneider, and G. Condorelly. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
15. Gu, Y., J. Rosenblatt, and D. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr 160 and Tyr 15. EMBO J. 11:3995-4005.
16. Guo, K., J. Wang, V. Andres, R. C. Smith, and K. Walsh. 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823-3829.
17. Guo, K., and K. Walsh. 1997. Inhibition of myogenesis by multiple cyclin-cdk complexes. J. Biol. Chem. 272:791-797.
18. Halevy, O., B. G. Nowitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
19. Hardy, S., Y. Kong, and S. F. Konieczny. 1993. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain. Mol. Cell. Biol. 13:5943-5956.
20. Hashimoto, N., M. Ogashiwa, E. Okumura, T. Endo, S. Iwashita, and T. Kishimoto. 1994. Phosphorylation of a proline-directed kinase motif is responsible for structural changes in myogenin. FEBS Lett. 352:236-242.
21. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28-35.
22. Horwitz, M. 1996. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD. Exp. Cell Res. 226:170-182.
23. Hunter, T., and M. Karin. 1992. The regulation of transcription by phosphorylation. Cell 70:375-387.
24. Labbé, J. C., J. C. Cavadore, and M. Dorée. 1991. M phase specific cdc2 kinase: preparation from starfish oocytes and properties. Methods Enzymol. 200:291-301.
25. Lamb, N. 6 January 1999. posting date. [Online.] PhosPepSort program. IGH, CNRS, Montpellier, France, http://www.genestream.org/phospepsort. [12 February 1999, last date accessed.]
26. Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadesch, C. Murr, A. Voronova, D. Baltimore, and H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315.
27. Lassar, A. B., S. X. Skapek, and B. Novitch. 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell. Biol. 6:788-794.
28. Lazaro, J. B., M. Kitzmann, M. A. Poul, M. Vandromme, A. Fernandez, and N. J. C. Lamb. 1997. Cyclin dependent kinase 5, cdk5. is a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110:1251-1260.
29. Li, T., J. Zhon, G. James, R. Heller-Harrison, M. P. Czoch, and E. N. Olson. 1992. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 71:1181-1194.
30. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136.
31. Murre, C., P. McCaw Schonleber, H. Vaessin, M. Caudy, L. Y. Jan, T. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, A. B. Lassar, H. Weintraub, and D. Baltimore. 1989. Interaction between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
32. Nielsen, D. A., T. C. Chang, and D. J. Shapiro. 1989. A highly sensitive, mixed-phase assay for chloramphenicol acetyl transferase activity in transfected cells. Anal. Biochem. 179:19-23.
33. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell 79: 547-550.
34. O'Farrell, P. H. 1975. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250:4007-4021.
35. Olson, E. N., E. Sternberg, J. S. Hu, G. Spizz, and C. Wilcox. 1986. Regulation of myogenic differentiation by type beta transforming growth factor. J. Cell Biol. 103:1799-1805.
36. Piette, J. 1990. Two adjacent MyoD1-binding sites regulate expression of the acetyl choline receptor α-subunit gene. Nature 345:353-355.
37. Pinset, C., D. Montarras, J. Chenevert, A. Minty, P. Barton, C. Laurent, and F. Gros. 1988. Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterisation of permissive and inducible C2 myoblasts. Differentiation 38:28-34.
38. Puri, P. L., M. L. Avantaggiati, C. Balsano, N. Sang, A. Graessmann, A. Giordano, and M. Levrero. 1997. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16:369-383.
39. Rao, S. S., C. Chu, and D. S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic-helix-loop-helix regulators. Mol. Cell. Biol. 14:5259-5267.
40. Rhodes, S. J., and S. F. Konbeczny. 1989. Identification of MRF4, a new member of the muscle regulatory factor gene family. Genes Dev. 9:2050-2061.
41. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
42. Simon, A. M., and S. J. Burden. 1993. An E-box mediates activation and repression of the acetylcholine receptor δ-subunit gene during myogenesis. Mol. Cell. Biol. 13:5133-5140.
43. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024.
44. Skapek, S. X., J. Rhee, P. S. Kim, B. G. Novitch, and A. B. Lassar. 1996. Cyclin D1 mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol. Cell. Biol. 16:7043-7053.
45. Slansky, J. F., and P. J. Farnham. 1996. Introduction to the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208: 1-30.
46. Song, A., Q. Wang, M. G. Goebl, and M. A. Harrington. 1998. Phosphorylation of nuclear MyoD is required for its rapid degradation. Mol. Cell. Biol. 18:4994-4999.
47. Songyang, Z., S. Blechner, N. Hoagland, M. F. Hoekstra, H. Piwnica-Worms, and L. C. Cantley. 1994. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr. Biol. 4:973-982.
48. Sorrentino, V., R. Pepperkok, R. L. Davis, W. Ansorge, and L. Pilipson. 1990. Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature 345:813-815.
49. Spin, G., D. Roman, A. Strauss, and E. N. Olson. 1986. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation. J. Biol. Chem. 261:9483-9488.
50. Tapscott, S. J., R. J. Davis, M. J. Thayer, P. Cheng, H. Weintraub, and A. B. Lassar. 1988. MyoD1: a nuclear phosphoprotein requiring a myc homology region to convert fibroblasts to myoblasts. Science 242:405-411.
51. Thayer, M. J., S. J. Tapscott, R. L. Davis, W. E. Wright, A. B. Lassar, and H. Weintraub. 1989. Positive autoregulation of the myogenic determination gene MyoD1. Cell 58:241-248.
52. Vandromme, M., C. Gauthier-Rouviere, G. Carnac, N. J. C. Lamb, and A. Fernandez. 1992. Serum response factor p67SRF is expressed and required during myogenic differentiation of both C2 and L6 muscle cell lines. J. Cell Biol. 118:1489-1500.
53. Vandromme, M., G. Carnac, C. Gauthier-Rouviere, D. Fesquet, N. J. C. Lamb, and A. Fernandez. 1994. Nuclear import of the myogenic factor MyoD requires cAMP-dependent protein kinase activity but not the direct phosphorylation of MyoD. J. Cell Sci. 107:613-620.
54. Vlach, J., S. Hennecke, and B. Amati. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. Genes Dev. 16: 5334-5344.
55. Weintraub, H., R. Davis, D. Lockshon, and A. Lassar. 1990. MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA 87:5623-5627.
56. Winter, B., T. Braun, and H. H. Arnold. 1993. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD. J. Biol. Chem. 268:9869-9878.
57. Wright, W. E., D. A. Sassoon, and W. K. Lin. 1989. Myogenin, a factor regulating myogenesis has a domain homologous to MyoD. Cell 56:607-617.
58. Zhou, J., and E. N. Olson. 1994. Dimerization through the helix-loop-helix motif enhances phosphorylation of the transcription activation domains of myogenin. Mol. Cell. Biol. 14:6232-6243.